• Vandaële E
  • PV 218
  • Août-septembre 2001
  • : Chien, chat

Références bibliographiques
Barthe L, Houin G,Woodley J.F, Lavit M, Michel F, Combal J.Ph. : In vitro intestinal degradation and absorption of a glycosaminoglycan drug, chondroitin sulfate ; Int. J. Pharm. Science (submitted).

Bénard P, Germain C, Bousquet E, Egal O. : Study of the distibution of radioactivity in a dog orally dosed with (acetyl-1-14C) Chondroitin Sulfate. British Small animal Veterinary Assocation Congress 2000.

Charlot J, Dreiser R.L, Loyau G, Masounabe-Puyanne A, Mazières B, Menkès C.J, Valat J.P. : La chondroïtine-sulfate dans le traitement de la gonarthrose et de la coxarthrose.Rev.Rhum.Mal. Ostéoartics. 1992;59 (7&8)1-6

Lequesne M. Les anti-arthrosiques symptomatiques d'action lente : un nouveau concept thérapeutique ? Rev. Rhum. 1994 ;61(2) :75-79

Uebelhart D, Thonar E.J.M.A, Delmas P.D, Chantraine A, Vignon E. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis : a pilot study. Osteoarthritis and cartilage. 1998;supplément A:39-46.

Bousquet E, Segal O. Efficacy of a Chondroïtine Sulfate based product on canine ostcoarthritis, WSAVA Congress Mondialvet 99, Lyon.

Spencer A. Osteoarthritis. Joint Anatomy, Physiology and Pathobiology. Veterinary clinics of North America. Small animal practive. Jonhonston, 1997;27(4):699-723

Chevalier X, Rousselin B, Ravaud P : Physiopathogénie de la maladie arthrosique. Synoviale (spéciale). 1999:4-17

Luke R. Chondroprotective agents. Glucosamine Salts and Chondroïtin sulfates. Towsend Letter for Doctors. Bucci, 1994;52-54

Baici A, Bradamante P. Interaction between human leucocyte elastase and chondroïtin sulfate. Chem. Biol interaction. 1984:1-11

Bassleer C, Henrotin Y, Franchimont P. In vitro evaluation of drugs as chondroprotective agents. Int. J. Tiss. Reac. 1992;Reac. XIV(5):231-241.

Chad L, Deal, Moskowitz Roland W. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroïtin sulfate and collagen Hydrolysalte. Rheumatic disease clinics of North America. 1999;25(2):379-395.

Mazières B, Loyau G, Menkes C.J, Valat J.P, Dreiser R.L, Charlot J, Masounable-Puyanne A. Chondroïtin Sulfate in the treatment of Gonarthrosis and Coxarthrosis. Revue du rhumatisme. 1992;59(7-8):379-395

Palmeri L, Cote A, Giovannini L, Lualdi P, Ronca G. Metabolic fate of exogeneous chondroïtin sulfate in the experimental animal. Arzneimittelforschung.Drug Res.1990;40(3):319-323.

McNamara Paul S, Spencer A. Johnston, Rory J. Slow acting, disease-modifying osteoarthritis agents. Veterinay clinics of North America. Small animal practice. 1997;27(4):863-867

McNamara Paul S, Barr Stephen C, Erb Holiis N. Hematologic, homeostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. 1996;AJVR 57 (9):1390-1394.

Goupille P. Efficacité et tolérance de chondrosulf 400 par voie orale dans la gonarthrose et pertinence clinique. Synoviale (spéciale):18-24.

Morrelae Pietro, Manopulo Roberto, Galati Michele, Boccanera Liciano. Saponati Giorgio, Bocchi Luigi. Comparaison of the antiinflammatory efficacy of chondroïtin sulfate and Diclofenac sodium in patients with knee osteoarthritis. The journal of rheumatology. 1996;23(8):1385-1391.

Vidal y Plana, R.R, Bizzari D, Rovati A.L. Articular cartilage pharmacology. In vitro studies on glucosamine and non steroïdal antiinflammatory drugs. Pharmacological Research. 1978;Communications 10(6):557-569.

Noack Wolfang, Fisher Michael. Förster Klauss K, Rovati Lucio C & Stenikar Ivo. Osteoarthritis and cartilage : Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Research Society. 1994;2:51-59.

Muller-Fabender H, Bach Gerhard L, Haasse Wolfgang, Rovati Lucio C., Stenikar Ivo. Osteorarhritis and cartilage : Glucosamine sulfate compared to Ibuprophen in osteoarthritis of the knee. Osteoarthritis Research Society. 1994;2:61-69.

Vas Antonio Lopez. Double blind clinical evaluation of relative efficacy of ibuprophen and glucosamine sulfate in the management of osteoarthritis of knee in out- patients. Current Medical Research and opinion. 1982;8(3):145-149.


En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d’intérêts.X
Pour en savoir plus et paramétrer les cookies...